AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,050,000 | +733.3% | 69,385 | +314.2% | 0.01% | +1200.0% |
| Q2 2022 | $126,000 | -84.0% | 16,750 | -85.1% | 0.00% | -75.0% |
| Q4 2021 | $789,000 | -50.3% | 112,421 | -19.3% | 0.00% | -42.9% |
| Q3 2021 | $1,588,000 | +3.5% | 139,314 | +45.4% | 0.01% | 0.0% |
| Q2 2021 | $1,534,000 | +109.8% | 95,787 | +134.2% | 0.01% | +75.0% |
| Q1 2021 | $731,000 | -35.5% | 40,895 | -51.2% | 0.00% | -33.3% |
| Q4 2020 | $1,133,000 | +415.0% | 83,849 | +348.3% | 0.01% | +500.0% |
| Q3 2020 | $220,000 | -25.9% | 18,705 | -7.0% | 0.00% | -50.0% |
| Q2 2020 | $297,000 | -92.5% | 20,110 | -93.2% | 0.00% | -94.6% |
| Q1 2020 | $3,963,000 | +2857.5% | 293,590 | +5178.5% | 0.04% | +3600.0% |
| Q4 2019 | $134,000 | -66.6% | 5,562 | -34.1% | 0.00% | -75.0% |
| Q1 2019 | $401,000 | -2.4% | 8,440 | -25.8% | 0.00% | 0.0% |
| Q4 2018 | $411,000 | +257.4% | 11,378 | +566.2% | 0.00% | +300.0% |
| Q2 2018 | $115,000 | -24.3% | 1,708 | -39.1% | 0.00% | 0.0% |
| Q1 2018 | $152,000 | -79.4% | 2,804 | -77.3% | 0.00% | -85.7% |
| Q4 2017 | $737,000 | +7.0% | 12,331 | -13.0% | 0.01% | +16.7% |
| Q3 2017 | $689,000 | +14.5% | 14,175 | +23.8% | 0.01% | +20.0% |
| Q2 2017 | $602,000 | +7.9% | 11,452 | -6.9% | 0.01% | 0.0% |
| Q1 2017 | $558,000 | +14.3% | 12,297 | -4.6% | 0.01% | +25.0% |
| Q4 2016 | $488,000 | +258.8% | 12,893 | +258.5% | 0.00% | +300.0% |
| Q3 2016 | $136,000 | +1.5% | 3,596 | -21.6% | 0.00% | 0.0% |
| Q4 2014 | $134,000 | – | 4,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |